Friday April 05, Paris

00.01 - 23.59
WCO-IOF-ESCEO
08.00 - 09.00
SYMPOSIA
Meeting Room 342A
Patients' preferences for anti-osteoarthritis treatment: A cross-European Discrete Choice Experiment: outcomes of an experts consensus meeting organized under the auspices of the European Society for Clinical and Economic Aspects of Osteoporosis, Osteoarthritis and Musculoskeletal Diseases (ESCEO).
Chairpersons: ‣ Mickaël Hiligsmann, ‣ Elaine M. Dennison
‣ 08:00: Welcome and introduction Mickaël Hiligsmann
‣ 08:05: Identification prioritization of important attributes of OA treatment Elaine M. Dennison
‣ 08:20: Results from the cross-European discrete choice experiment Mickaël Hiligsmann
‣ 08:35: Discussion Elaine M. Dennison
‣ 08:55: Conclusion Mickaël Hiligsmann
Meeting Room 351
Osteosarcopenic obesity: enough evidence for a distinct entity: outcomes of an ESCEO experts consensus meeting organized under the auspices of the World Health Organization Collaborating Center for Public Health Aspects of Musculo-skeletal Health and Ageing
Chairpersons: ‣ Islene Araujo de Carvalho, ‣ Roger A. Fielding
‣ 08:00: Introduction Stefania Maggi
‣ 08:05: Osteosarcopenic obesity: Facts and evidence supporting a distinct entity Jürgen Bauer
‣ 08:20: Osteosarcopenic obesity: Lack of evidence supporting a distinct entity Alfonso Cruz Jentoft
‣ 08:35: Discussion Jürgen Bauer
‣ 08:55: Conclusion Roger A. Fielding
Panel: ‣ Islene Araujo de Carvalho, ‣ Jürgen Bauer, ‣ Olivier Bruyère, ‣ Roland D. Chapurlat, ‣ Cyrus Cooper, ‣ Alfonso Cruz Jentoft, ‣ Elaine M. Dennison, ‣ Roger A. Fielding, ‣ John A. Kanis, ‣ Jean‑Marc Kaufman, ‣ Francesco Landi, ‣ Andrea Laslop, ‣ Médéa Locquet, ‣ Stefania Maggi, ‣ Eugene McCloskey, ‣ Simone Perna, ‣ Jean‑Yves Reginster, ‣ René Rizzoli, ‣ Yves Rolland, ‣ Pawel Szulc
08.00 - 09.00
NON-SPONSORED SYMPOSIA
Meeting Room 352A
Real World Evidence in Metabolic Bone Disease
Chairperson: ‣ Daniel Prieto‑Alhambra
‣ Real world data for assessing the use, risks, and benefits of anti-osteoporosis therapies in actual practice conditions Daniel Prieto‑Alhambra
‣ Routinely collected data for the study of the epidemiology of fractures, and for characterising imminent fracture risk Bo Abrahamsen
‣ Health economics using real world data: an introduction Rafael Pinedo‑Villanueva
‣ Real world data for the study of orthopaedics and hip fracture care Alma Pedersen
Meeting Room 341
What’s new in tendinopathies?
Chairperson: ‣ Jean‑François Kaux
‣ Introduction Olivier Bruyère
‣ Tendon physiopathology and imagery... What’s new ? Stijn Bogaerts
‣ Rehabilitation: eccentric or not eccentric? Which physiotherapy? Jean‑Louis Croisier
‣ Which efficacy for the new treatments ? Jean‑François Kaux
Meeting Room 353
Emerging Biomarkers in Vitamin D Metabolism
Chairperson: ‣ Shaun Sabico
‣ Biomarker Discovery Nasser Al‑Daghri
‣ Vitamin D Biomarker Discovery Majed Alokail
‣ Validation Yousef  Al‑Saleh
Meeting Room 343
Sarcopenia in older people: actual perspectives
Chairpersons: ‣ Nicola Veronese, ‣ Charlotte Beaudart
‣ The radiological evaluation of muscle mass in older people Giuseppe Guglielmi
‣ Physical performance in older people: actual evidence Olivier Bruyère
‣ The diagnosis of sarcopenia in older people: between research and clinical practice Nicola Veronese
Meeting Room 342B
Female Bone Health: a gynecological approach through routine assistance
Chairperson: ‣ Adriana Orcesi Pedro
‣ Opening: Women´s Hospital - CAISM - University of Campinas message for bone health Adriana Orcesi Pedro
‣ Bone mass and fracture risk during pregnancy and lactation Anna V. Gueldini de Moraes, Fernanda Garanhani de Castro Surita
‣ Update on management of osteoporosis in young women - special clinical situations Adriana Orcesi Pedro, Gabriela Pravatta Rezende
‣ Evaluation and management of osteopenia and osteoporosis in breast cancer survivors Adriana Orcesi Pedro, Cesar Cabello dos Santos
‣ Question & Answers with audience
09.00 - 10.30
Auditorium A
SCIENTIFIC SESSION I
Chairpersons: ‣ Jean‑Yves Reginster, ‣ John A. Kanis
09.00
Auditorium A
Plenary Lecture 1
‣ When and why use a bone forming agent?
‣ Eugene McCloskey
09.30
Auditorium A
Oral communication selected from abstracts
09.30
Auditorium A
OC1
‣ HORMONE THERAPY REDUCES THE RISK OF FRACTURE IN FALLERS AND IN NON-FALLERS: RESULTS FROM THE WOMEN’S HEALTH INITIATIVE HORMONE THERAPY TRIALS
Presenting author: ‣ M. Lorentzon
Authors: ‣ H. Johansson, ‣ N. C. Harvey, ‣ E. Liu, ‣ J. Crandall, ‣ E. V. McCloskey, ‣ J. A. Kanis
09.40
Auditorium A
OC2
‣ ROMOSOZUMAB EFFICACY ON FRACTURE OUTCOMES IS GREATER IN PATIENTS AT HIGH BASELINE FRACTURE RISK: A POST HOC ANALYSIS OF THE FRAME STUDY
Presenting author: ‣ E. V. McCloskey
Authors: ‣ M. Lorentzon, ‣ H. Johansson, ‣ N. C. Harvey, ‣ J. A. Kanis
09.50
Auditorium A
OC3
‣ ROMOSOZUMAB ENHANCES 3D VERTEBRAL STRUCTURE IN WOMEN WITH LOW BONE DENSITY: MAPPING BONE GAINS AT ONE YEAR COMPARED WITH TERIPARATIDE OR PLACEBO
Presenting author: ‣ K. E. S. Poole
Authors: ‣ G. M. Treece, ‣ R. A. Pearson, ‣ A. H. Gee, ‣ M. A. Bolognese, ‣ J. P. Brown, ‣ S. Goemaere, ‣ A. Grauer, ‣ D. A. Hanley, ‣ C. Mautalen, ‣ C. Recknor, ‣ Y. C. Yang, ‣ C. Libanati, ‣ T. Whitmarsh
10.00
Auditorium A
OC4
‣ EFFECT OF ABALOPARATIDE ON BONE MINERAL DENSITY AND FRACTURE INCIDENCE IN POSTMENOPAUSAL WOMEN WITH OSTEOPOROSIS AND OSTEOARTHRITIS
Presenting author: ‣ N. E. Lane
Authors: ‣ B. Mitlak, ‣ R. Weiss, ‣ Y. Wang, ‣ G. J. Valenzuela, ‣ J. P. Bilezikian
10.10
Auditorium A
OC5
‣ BUROSUMAB IMPROVES THE BIOCHEMICAL, SKELETAL, AND CLINICAL SYMPTOMS OF TUMOR-INDUCED OSTEOMALACIA (TIO) SYNDROME
Presenting author: ‣ S. Jan de Beur
Authors: ‣ P. Miller, ‣ T. Weber, ‣ M. Peacock, ‣ K. Insogna, ‣ R. Kumar, ‣ D. Luca, ‣ T. Cimms, ‣ K. Lampl, ‣ J. San Martin, ‣ T. Carpenter
10.20
Auditorium A
Presentation of the ESCEO-AgNovos Healthcare Young Investigator Awards
‣ Jean‑Yves Reginster
10.30 - 12.10
Auditorium A
SCIENTIFIC SESSION II
Chairpersons: ‣ René Rizzoli, ‣ Cyrus Cooper
10.30
Auditorium A
Presentation of the ESCEO-IOF Herbert Fleisch Medal
‣ René Rizzoli
10.40
Auditorium A
Plenary Lecture 2
‣ Bone fragility and its treatment in chronic renal failure
‣ Peter R. Ebeling
11.10
Auditorium A
Presentation of the IOF President's Award
‣ Cyrus Cooper
11.20
Auditorium A
Oral communication selected from abstracts
11.20
Auditorium A
OC6
‣ IMMINENT (1- AND 2-YEAR) FRACTURE RISK FOLLOWING A FIRST (SENTINEL) FRACTURE: A MULTINATIONAL EUROPEAN COHORT STUDY INCLUDING OVER 700,000 PARTICIPANTS FROM DENMARK, SPAIN, AND THE UK
Presenting author: ‣ D. Prieto‑Alhambra
Authors: ‣ S. Khalid, ‣ M. Thomsen Ernst, ‣ M. K. Javaid, ‣ C. Libanati, ‣ C. Cooper, ‣ A. Delmestri, ‣ D. Martinez‑Laguna, ‣ E. Toth, ‣ B. Abrahamsen
11.30
Auditorium A
OC7
‣ ADJUSTING FRAX FOR IMMINENT RISK
Presenting author: ‣ H. Johansson
Authors: ‣ K. Siggeirsdottir, ‣ N. C. Harvey, ‣ E. V. McCloskey, ‣ V. Gudnason, ‣ G. Sigurdsson, ‣ M. Lorentzon, ‣ E. Liu, ‣ J. A. Kanis
11.40
Auditorium A
OC8
‣ AGE AT HIP FRACTURE: TIME TRENDS OVER TWO DECADES IN A NATIONAL HOSPITAL DISCHARGE REGISTER
Presenting author: ‣ B. Abrahamsen
Authors: ‣ H. V. B. Laursen, ‣ M. K. Skjødt, ‣ M. H. Jensen, ‣ P. Vestergaard
11.50
Auditorium A
OC9
‣ T-SCORE AS AN INDICATOR OF FRACTURE RISK ON THERAPY: EVIDENCE FROM ROMOSOZUMAB VS. ALENDRONATE TREATMENT IN THE ACTIVE-CONTROLLED FRACTURE STUDY IN POSTMENOPAUSAL WOMEN WITH OSTEOPOROSIS AT HIGH RISK TRIAL
Presenting author: ‣ S. Ferrari
Authors: ‣ F. Cosman, ‣ E. M. Lewiecki, ‣ P. R. Ebeling, ‣ E. Hesse, ‣ N. Napoli, ‣ D. B. Crittenden, ‣ M. Rojeski, ‣ W. Yang, ‣ C. Libanati
12.00
Auditorium A
OC10
‣ FRACTURE INCIDENCE AFTER DENOSUMAB DISCONTINUATION: REAL-WORLD DATA FROM A LARGE HEALTHCARE PROVIDER
Presenting author: ‣ L. Tripto‑Shkolnik
Authors: ‣ N. Fund, ‣ V. Rouach, ‣ G. Chodick, ‣ V. Shalev, ‣ I. Goldshtein
13.45 - 14.00
Podium
IOF Calcium Academy Awards ceremony
‣ Bess Dawson‑Hughes
14.00 - 15.00
MEET-THE-EXPERT SESSIONS
Meeting Room 341
How to assess frailty in daily practice ?
‣ Evelien Gielen
Meeting Room 353
Pre- and postnatal influences on bone and muscle health in children
‣ Nicholas Harvey
Meeting Room 343
Strengths of recommendations for GIOP management
‣ Jonathan Adachi
Meeting Room 352A
Local therapies in osteoarthritis management
‣ François Rannou
Meeting Room 342B
New algorithm for the management of bone fragility in diabetes
‣ Serge Ferrari
14.00 - 15.00
Poster Area
Poster Viewing Session I
14.00 - 15.10
Podium
Oral presentation of selected posters
Chairperson: ‣ Tara Brennan‑Speranza
14.00
Podium
P893
‣ IDENTIFICATION OF PATIENTS AT HIGH RISK FOR OSTEOPOROTIC FRACTURES THROUGH RADIOFREQUENCY ECHOGRAPHIC MULTI SPECTROMETRY (REMS): RESULTS OF A 5-YEAR FOLLOW-UP STUDY
Presenting author: ‣ C. Caffarelli
Authors: ‣ S. Gonnelli, ‣ G. Bianchi, ‣ M. L. Brandi, ‣ S. Casciaro, ‣ L. Cavalli, ‣ L. Cianferotti, ‣ F. Conversano, ‣ A. Fassio, ‣ G. Girasole, ‣ A. Grimaldi, ‣ F. A. Lombardi, ‣ M. Muratore, ‣ P. Pisani, ‣ L. Quarta, ‣ D. Gatti
14.07
Podium
P927
‣ PATIENT AND SERVICE-LEVEL PREDICTORS OF BONE TREATMENT RECOMMENDATION POST-FRACTURE: RESULTS FROM THE UK NATIONAL FRACTURE LIAISON SERVICE (FLS) DATABASE
Presenting author: ‣ M. K. Javaid
Authors: ‣ S. Hawley, ‣ N. Vasilakis, ‣ B. Wiles, ‣ C. L. Gregson, ‣ N. Gittoes, ‣ G. Clunie, ‣ C. Cockill, ‣ I. Price, ‣ A. Judge, ‣ A. Smith
14.14
Podium
P363
‣ FRAILTY IN OLDER COMMUNITY DWELLING ADULTS: A COMPARATIVE STUDY OF THE UK AND JAPAN
Presenting author: ‣ N. Yoshimura
Authors: ‣ E. M. Dennison, ‣ K. A. Jameson, ‣ S. Tanaka, ‣ T. Iidaka, ‣ C. Cooper
14.21
Podium
P154
‣ EWGSOP 2 VERSUS EWGSOP 1: IMPACT ON THE PREVALENCE OF SARCOPENIA AND ITS OUTCOMES
Presenting author: ‣ M. Locquet
Authors: ‣ C. Beaudart, ‣ J. Petermans, ‣ O. Bruyère
14.28
Podium
P639
‣ DIFFUSE IDIOPATHIC SKELETAL HYPEROSTOSIS IS A NEW RISK FACTOR FOR VERTEBRAL FRACTURE IN OLDER MEN – THE PROSPECTIVE MINOS STUDY
Presenting author: ‣ P.  Szulc
Authors: ‣ A. Guiot, ‣ R. D. Chapurlat
14.35
Podium
P837
‣ FOR ALL PRACTITIONERS AND RESEARCHERS TO ASSESS HAND DYSFUNCTION IN HAND OSTEOARTHRITIS (OA): THE QUICK, FRIENDLY AND AVAILABLE FOR FREE FUNCTIONAL INDEX FOR HAND OA WEBSITE FIHOA.NET
Presenting author: ‣ E. Maheu
Author: ‣ R.‑L. Dreiser
14.42
Podium
P586
‣ IMMINENT FRACTURE RISK AMONGST NEW USERS OF ORAL BISPHOSPHONATES IN ACTUAL PRACTICE SETTINGS: A MULTI-NATIONAL EUROPEAN COHORT STUDY FROM DENMARK, SPAIN, AND THE UK
Presenting author: ‣ D. Prieto‑Alhambra
Authors: ‣ S. Khalid, ‣ M. Thomsen Ernst, ‣ M. K. Javaid, ‣ C. Libanati, ‣ C. Cooper, ‣ A. Delmestri, ‣ D. Martinez‑Laguna, ‣ E. Toth, ‣ B. Abrahamsen
14.49
Podium
P701
‣ RISK OF HAND OSTEOARTHRITIS IN NEW USERS OF HORMONE REPLACEMENT THERAPY: A NESTED CASE-CONTROL ANALYSIS
Presenting author: ‣ T. Burkard
Authors: ‣ M. Rauch, ‣ J. Spoendlin, ‣ D. Prieto‑Alhambra, ‣ S. S. Jick, ‣ C. R. Meier
14.56
Podium
P1041
‣ CAN WE AVOID THE LOSS OF BONE MINERAL DENSITY ONE YEAR AFTER DENOSUMAB DISCONTINUATION? THE REOLAUS BONE PROJECT
Presenting author: ‣ B. Aubry‑Rozier
Authors: ‣ G. Liebich, ‣ D. Stoll, ‣ E. Gonzalez‑Rodriguez, ‣ D. Hans, ‣ O. Lamy
15.03
Podium
P698
‣ MAJOR OSTEOPOROTIC FRACTURE RISK FOLLOWING BARIATRIC SURGERY: A SELF-CONTROLLED CASE SERIES INCLUDING 5,492 PEOPLE FROM THE UK CPRD AND LINKED HES DATABASES
Presenting author: ‣ D. E. Robinson
Authors: ‣ I. Douglas, ‣ G. D. Tan, ‣ C. Cooper, ‣ A. Delmestri, ‣ M. K. Javaid, ‣ A. Judge, ‣ V. Y. Strauss, ‣ D. Prieto‑Alhambra
14.00 - 15.00
SYMPOSIA
Meeting Room 342A
Reassessment of the safety of anti-osteoarthritis medications: outcomes of an experts consensus meeting organized under the auspices of the European Society for Clinical and Economic Aspects of Osteoporosis, Osteoarthritis and Musculoskeletal Diseases (ESCEO).
Chairpersons: ‣ Olivier Bruyère, ‣ Elaine M. Dennison
‣ 14:00: Welcome and scope of the problem Cyrus Cooper
‣ 14:05: Methodology of the ESCEO Working Group Cyrus Cooper
‣ 14:15: Safety of analgesics, non-steroidal anti-inflammatory drugs and opioids Nicholas R. Fuggle
‣ 14:30: Safety of SYSADOAs, intraarticular Hyaluronic Acid and intraarticular corticosteroids Tim McAlindon
‣ 14:45: Discussion Nigel K. Arden
‣ 14:55: Wrap-up and conclusions Nigel K. Arden
Meeting Room 351
Determinants, consequences and potential solutions to poor adherence to anti-osteoporosis treatment: outcomes of an ESCEO-IOF experts consensus meeting organized under the auspices of the WHO Collaborating Centre for Public Health Aspects of Musculoskeletal Health and Aging
Chairpersons: ‣ Adolfo Diez‑Perez, ‣ Stefania Maggi
‣ 14:00: Welcome and scope of the problem Maria Luisa Brandi
‣ 14:05: Determinants of non-adherence to anti-osteoporosis medications Bernard Vrijens
‣ 14:20: Recommendations to improve adherence to anti-osteoporosis medications Mickaël Hiligsmann
‣ 14:35: Recommendations for additional research needed to improve adherence to anti-osteoporosis medications Bo Abrahamsen
‣ 14:45: Discussion (Leader : Sansin Tuzun)
‣ 15:00: Closure of the meeting Adolfo Diez‑Perez
15.00 - 17.00
Auditorium A
SCIENTIFIC SESSION III
Chairpersons: ‣ Charlotte Beaudart, ‣ Bess Dawson‑Hughes
15.00
Auditorium A
Plenary Lecture 3
‣ Early treatment of osteoarthritis
‣ Nigel K. Arden
15.30
Auditorium A
Oral communication selected from abstracts
15.30
Auditorium A
OC11
‣ CARDIOVASCULAR COMORBIDITIES HAS A DELETERIOUS INFLUENCE ON KNEE OA PROGNOSIS AT 5 YEARS: DATA FROM THE PROSPECTIVE KHOALA COHORT
Presenting author: ‣ C. Roubille
Authors: ‣ J. Joel, ‣ S. Sellam, ‣ A. C. Rat, ‣ F.  Guillemin, ‣ C. Roux
15.40
Auditorium A
OC12
‣ PREVALENCE OF SARCOPENIA ACCORDING TO THE REVISED EWGSOP DEFINITION AND ITS ASSOCIATIONS WITH BONE STRUCTURE AND INCIDENT FALLS IN SWEDISH OLDER ADULTS
Presenting author: ‣ D. Scott
Authors: ‣ J. Johansson, ‣ L. B. McMillan, ‣ P. R. Ebeling, ‣ P. Nordstrom, ‣ A. Nordstrom
15.50
Auditorium A
OC13
‣ STRENGTH AND PERFORMANCE-BASED OPERATIONAL MEASURES OF SARCOPENIA: PREVALENCE AND ASSOCIATIONS WITH SOCIAL FACTORS AND PHYSICAL DISABILITY IN 10,461 ADULTS AGED 65 YEARS AND OVER FROM SIX LOWER- AND MIDDLE-INCOME COUNTRIES
Presenting author: ‣ S. L. Brennan‑Olsen
Authors: ‣ S. J. Bowe, ‣ P. Kowal, ‣ J. Gaskin, ‣ N. Naidoo, ‣ J. Snodgrass, ‣ T. Quashie, ‣ S. Agrawal, ‣ G. Eick, ‣ C. D'Este
16.00
Auditorium A
OC14
‣ WHICH MUSCLE PARAMETERS ARE LONGITUDINALLY ASSOCIATED WITH FUTURE KNEE OSTEOARTHRITIS OUTCOMES? FINDINGS FROM THE HERTFORDSHIRE COHORT STUDY
Presenting author: ‣ N. R. Fuggle
Authors: ‣ L. D. Westbury, ‣ K. A. Jameson, ‣ H. E. Syddall, ‣ M. H. Edwards, ‣ K. A. Ward, ‣ E. M. Dennison, ‣ C. Cooper
16.10
Auditorium A
OC15
‣ PATIENT ENGAGEMENT IN CLINICAL GUIDELINES DEVELOPMENT: INPUT FROM >1000 MEMBERS OF THE CANADIAN OSTEOPOROSIS PATIENT NETWORK
Presenting author: ‣ L. Funnell
Authors: ‣ M. Djekic‑Ivankovic, ‣ R. Chepesiuk, ‣ L. Giangregorio, ‣ I. Braganca Rodrigues, ‣ R. Ridout, ‣ S. Feldman, ‣ S. Kim, ‣ H. Mcdonald‑Blumer, ‣ G. Kline, ‣ W. E. Ward, ‣ N. Santesso, ‣ W. D. Leslie, ‣ S. N. Morin
16.20
Auditorium A
OC16
‣ RISK OF MAJOR OSTEOPOROTIC FRACTURE AFTER BARIATRIC SURGERY IN FRANCE: POPULATION BASED, RETROSPECTIVE COHORT STUDY
Presenting author: ‣ J. Paccou
Authors: ‣ N. Martignène, ‣ E. Lespessailles, ‣ G. Babykina, ‣ B. Cortet, ‣ G. Ficheur
16.30
Auditorium A
Plenary Lecture 4
‣ Guidelines for the management of osteoarthritis
‣ Jean‑Yves Reginster
15.00 - 16.45
Meeting Room 351
COMMITTEE OF NATIONAL SOCIETIES SPECIAL PLENARY SESSION
‣ Clinical, social, ethical and economic burden of osteoporosis and fragility fractures
Chairpersons: ‣ Jean‑Yves Reginster, ‣ Famida Jiwa, ‣ Philippe Halbout
15.03
Meeting Room 351
OCs1
‣ DETERMINANTS AND HEALTH CONSEQUENCES OF A RAPID MUSCLE HEALTH DECLINE IN OLDER ADULTS FROM THE SARCOPHAGE STUDY
Presenting author: ‣ M. Locquet
Authors: ‣ C. Beaudart, ‣ J.‑L. Croisier, ‣ J.‑Y. Reginster, ‣ O. Bruyère
15.11
Meeting Room 351
OCs2
‣ THE ASSOCIATION BETWEEN RESTING METABOLIC RATE (RMR) AND SARCOPENIC OBESITY (SO) IN OVERWEIGHT AND OBESE ADULT WOMEN
Presenting author: ‣ K. Mirzaei
Authors: ‣ N. Rasaei, ‣ S. F. Sajjadi, ‣ S. A. Keshavarz
15.19
Meeting Room 351
OCs3
‣ WILL THERE BE A FRACTURE IN THEIR FUTURE? BONE MINERAL DENSITY FINDINGS IN YOUNG SOUTH EAST ASIAN WOMEN WITH ANOREXIA NERVOSA
Presenting author: ‣ M. Chandran
Author: ‣ Y. Hao
15.27
Meeting Room 351
OCs4
‣ THE BENEFITS OF REGULAR WEIGHT BEARING ACTIVITY THROUGHOUT THE LIFE-COURSE: DO MEN AND WOMEN REAP THE SAME REWARDS?
Presenting author: ‣ J. Zhang
Authors: ‣ M. A. Clynes, ‣ K. A. Jameson, ‣ C. Cooper, ‣ E. M. Dennison
15.35
Meeting Room 351
OCs5
‣ ASSOCIATION OF 25-HYDROXY VITAMIN D WITH BONE TURNOVER MARKERS AND BONE MINERAL DENSITY IN AN IRANIAN ELDERLY POPULATION: BUSHEHR ELDERLY HEALTH (BEH) PROGRAM
Presenting author: ‣ S. Gharibzadeh
Authors: ‣ N. Fahimfar, ‣ G. Shafiee, ‣ R. Heshmat, ‣ N. Mehrdad, ‣ F. Razi, ‣ P. Khashayar, ‣ A. Raiesei, ‣ I. Nabipour, ‣ B. Larijani, ‣ A. Ostovar
15.45
Meeting Room 351
Presentation of the IOF Committee of National Societies Medal
‣ Jean‑Yves Reginster
15.55
Meeting Room 351
OCs6
‣ SERUM VITAMIN D LEVEL ASSOCIATED WITH COGNITIVE AND PHYSICAL FUNCTIONING OF POSTMENOPAUSAL WOMEN
Presenting author: ‣ A. A. Popov
Authors: ‣ N. V. Izmozherova, ‣ E. A. Safianik, ‣ A. A. Vikhareva, ‣ V. M. Bakhtin, ‣ M. A. Shambatov
16.03
Meeting Room 351
OCs7
‣ POSTPARTUM OSTEOPOROSIS ASSOCIATED WITH VERTEBRAL FRACTURES
Presenting author: ‣ N. Temelkova
Authors: ‣ A. Gerganova, ‣ K. Temelkova, ‣ K. Sirakova, ‣ P. Popivanov
16.11
Meeting Room 351
OCs8
‣ VALIDATION OF THE FRACTURE RISK ASSESSMENT TOOL (FRAX) CALCULATOR IN TAIWAN-TWO COHORTS STUDY
Presenting author: ‣ W.‑C. Hung
Authors: ‣ C. H. Wu, ‣ F. W. Liang, ‣ I. T. Liu, ‣ Y. F. Chang, ‣ L. C. Ou, ‣ C. S. Chang, ‣ T. H. Lu
16.19
Meeting Room 351
OCs9
‣ PREVALENCE OF SARCOPENIA IN INDIAN MEN AND WOMEN VARIES ACCORDING TO THE DEFINITION USED
Presenting author: ‣ A. Zengin
Authors: ‣ B. Kulkarni, ‣ A. V. Khadilkar, ‣ V. Ekbote, ‣ N. Kajale, ‣ N. Tandon, ‣ S. K. Bhargava, ‣ H. P. S. Sachdev, ‣ S. Sinha, ‣ C. H. D. Fall, ‣ P. R. Ebeling
16.27
Meeting Room 351
OCs10
‣ VERTEBRAL PAIN AND PHYSICAL PERFORMANCE INDICES IN POSTMENOPAUSAL WOMEN WITH VERTEBRAL FRACTURES DEPENDING ON BONE MINERAL DENSITY PARAMETERS
Presenting author: ‣ N. Grygorieva
Authors: ‣ V. Povoroznyuk, ‣ O. Rybina
16.35
Meeting Room 351
OCs11
‣ FAMILY HISTORY INFLUENCES FRACTURE RISK BMD- INDEPENDENTLY
Presenting author: ‣ A. I. Gasparik
Authors: ‣ M. L. Cevei, ‣ D. Stoicanescu, ‣ T. Szocs